High prevalence of low serum paraoxonase-1 in subjects with coronary artery disease

Journal of Clinical Biochemistry and Nutrition

Volumn 45, Issue 3, 2009, Pages 278-284

  Jayakumari, Narayani ^a   Thejaseebai, Gopalan ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Atherosclerosis; HDL; Oxidativestress; Paraoxonase

Indexed keywords

ALPHA TOCOPHEROL; ARYLDIALKYLPHOSPHATASE 1; ASCORBIC ACID; BETA CAROTENE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID PEROXIDE; MALONALDEHYDE; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; ENZYME ACTIVITY; HUMAN; LIFESTYLE; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SMOKING HABIT; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

EID: 70549105792     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.08-255     Document Type: Article

References (27)

1. Ross, R.: Atherosclerosis an inflammatory disease. New Engl. J. Med., 340, 115-118, 1999.
2. Watson, A.D., Berliner, J.A., Hama, S.Y., La Du, B.N., Fuall, K.F., Fogelman, A.M., and Navab, M.: Protective effect of HDL-paraoxonase: inhibition of the biological activity of minimally oxidized LDL. J. Clin. Invest., 96, 2882-2891, 1996.
3. Mackness, M.I., Arrol, S., and Durrington, P.N.: Paraoxonase prevents accumulation of lipid peroxides in LDL. FEBS Lett., 286, 152-154, 1991.
4. Mackness, M.I., Abott, C.A., Arrol, S., and Durrington, P.N.: The role of HDL and lipid soluble antioxidant vitamins in inhibiting LDL oxidation. Biochem. J., 294, 829-835, 1993.
5. Durrington, P.N., Mackness, B., and Mackness, M.I.: Paraoxonase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 21, 473-480, 2001.
6. Mackness, M.I., Mackness, B., Durrington, P.N., Connelly, P.W., and Hegele, R.A.: Paraoxonase: Biochemistry, genetics and relationship to plasma lipoproteins. Curr. Opin. Lipidol., 7, 69-76, 1996.
7. Aviram, M., Rosenblat, M., Billecke, S., Erogul, J., Sorenson, R., Bisgaier, C.L., Newton, R.S., and La Du, B.: Human serum paraoxonase is inactivated by oxidized LDL and reserved by antioxidants. Free Radic. Biol. Med., 26, 892-904, 1999.
8. Ayub, A., Mackness, M.I., Arrol, S., Mackness, B., Patel, J., and Durrington, P.N.: Serum paraoxonase after myocardial infarction. Arterioscler. Thromb. Vasc. Biol., 19, 330-335, 1999.
9. Mackness, B., Davies, G.K., Turkie, W., Lee, E., Roberts, D.H., Hills, E., Roberts, C., Durrington, P.N., and Mackness, M.I.: Paraoxonase status in coronary artery disease: are activity and concentration more important than genotype? Arterioscler. Thromb. Vasc. Biol., 21, 1451-1457, 2001.
10. Mackness, B., Durrington, P., McElduff, P., John, Y., Naheed, A., Michael, W., and Michael, M.: Low paraoxonase activity predicts coronary events in the Caerphelly prospective study. Circulation, 107, 2775-2779, 2003. (Pubitemid 36705985)
11. Shih, D.M., Gu, L., Xia, Y.R., Navab, M., Li, W.F., Hama, S., Castellani, L.W., Furlong, C.E., Costa, L.G., Fogelman, A.M., and Lusis, A.J.: Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature, 394, 284-287, 1998. (Pubitemid 28335041)
12. Tward, A., Xia, Y.-R., Wang, X.-P., Shi, Y.-S., Park, C., Castellani, L.W., Lusis, A.J., and Shih, D.M.: Decreased Atherosclerotic Lesion Formation in Human Serum Paraoxonase Transgenic Mice. Circulation, 106, 484-490, 2002. (Pubitemid 34803695)
13. Aviram, M., Hardak, E., Vaya, J., Mahmood, S., Milo, S., Hoffman, A., Billicke, S., Draganov, D., and Rosenblat, M.: Human serum Paraoxonase Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON-1 esterase and peroxides-like activities. Circulation, 101, 2510-2517, 2000. (Pubitemid 30366256)
14. Player, J.R., Eza, L.C., Bullen, M.F., and Evans, D.A.P.: Genetic polymorphism and inter-ethnic variability of plasma paraoxonase-1 activity, J. Med. Genet., 13, 337-342, 1976.
15. Jayakumari, N., Ambikakumari, V., Balakrisgnan, K.G., and Iyer, K.S.: Distribution of cholesterol in HDL and its sub fractions in patients with coronary atherosclerotic heart disease. Ind. Heart J., 45, 265-268, 1993.
16. Jayakumari, N., Ambikakumari, V., Balanrishnan, K.G., and Iyer, K.S.: Antioxidant status in relation to free radical production during stable and unstable anginal syndromes. Atherosclerosis, 94, 183-190, 1992.
17. Beuge, J.A. and Aust, S.D.: Thiobarbituric acid assay for lipid peroxides. Methods Enzymol., 52, 306-310, 1978.
18. Desai, D.: Vitamin E analysis, methods for animal tissues. Methods Enzymol., 105, 138-147, 1984.
19. Omaye, S.T., Turnbull, J.D., and Sauberlich, H.E.: Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids. Methods Enzymol., 62, 9-11, 1979.
20. McCormick, D.B.: Vitamins: Methods for determination of vitamin A and β-carotene, in Textbook of Clinical Chemistry, ed. By N.W., Tietz, W.B, Saunders company, West Washington square, Philadelphia, 932-934, 1986.
21. Lorenz, K., Flatter, B., and Augustine, E.: Aryl esterase in serum: Elaboration and clinical application of fixed incubation method. Clin. Chem., 25, 1714-1720, 1979.
22. Jarvick, G.P., Hatsukami, T.S., Carlson, C., Richter, R.J., Jampsa, R., Brophy, V.H., Margolin, S., Rieder, M., Nickerson, D., Schellenberg, G.D., Heagerty, P.J., and Furlong, C.E.: Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease. Arterioscler. Thromb. Vasc. Biol., 23, 1465-1471, 2003.
23. Boemi, M., Leviev, I., Sirolla, C., Pieri, C., Marra, M., and James, R.W.: Serum paraoxonase is reduced in type 1 diabetes compared to non-diabetic, first-degree relatives: Influence of the ability of HDL to protect LDL from oxidation. Atherosclerosis, 155, 229-235, 2001. (Pubitemid 32167144)
24. Agachen, B., Yilmaz, H., Karaali, Z., and Ishir, T.: Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and lipids in urkish patients with non-insulin dependent diabetes mellitus. Cell Biochem. Funct., 22, 163-168, 2004.
25. Kopprasch, S., Pietzch, J., Kuhlish, E., and Graessier, J.: Lack of association between serum paraoxonase activities and increased oxidation of LDL in impaired glucose tolerance and newly diagnosed diabetes mellitus. J. Clin. Endocrinol. Metab., 88, 1711-1716, 2003.
26. Aviram, M., Domfeld, L., Rosenblat, M., Volkova, N., Kaplan, M., Coleman, R., Hayek, T., Presser, D., and Fubrman, B.: Pomegranate juice consumption reduces oxidative stress, atherogenic modification of LDL and platelet aggregation: Studies in human and atherosclerotic apo-E deficient mice. Am. J. Clin. Nutr., 71, 1062-1076, 2000.
27. van der Gaag, M.S., van Tol, A., Scheek, L.M., James, R.W., Urgert, R., Schaafsma, G., and Hendriks, H.F.: Daily moderate alcohol consumption increases serum paraoxonase activity, a diet-controlled, randomized intervention study in middle-aged men. Atherosclerosis, 147, 405-410, 1999. (Pubitemid 29512273)